hotspot -WSS

hotspot

author：focus 2025-10-01 14:20:08 - browse：27112

Photo illustration of the FDA US Food and Drug website. -- health policy coverage from STAT — Adobe

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday.

The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility. An investigation found that the delayed response was due in part to the agency’s organization. A nonprofit, nonpartisan advisory body reported in December it was not clear who is in charge of food oversight, and agency food safety staff are siloed among divisions that don’t communicate with each other.

Although the food center has been the focus of attention in the reorganization, it will affect a huge swath of the agency. The reorganization is expected to impact about 8,000 FDA employees, according to Michael Rogers, FDA associate commissioner for regulatory affairs. The Office of Regulatory Affairs, which will be called the Office of Inspections and Investigations under the proposed reorganization, will go from having about 5,100 full-time employees to 3,586 employees.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： What should King Charles tell the public about his cancer?

focus

WSS

Medicare threatens to cut off funding for HCA's Mission hospital

Industry veterans launch new biotech VC with $310M

Senators start work on Medicare physician payment reform

Robert F. Kennedy is pitching centrism on health, even on abortion

5 takeaways from STAT's examination of Zynex Medical

Robert F. Kennedy is pitching centrism on health, even on abortion

explore

hotspot

leisure time

Drug repurposing or repositioning? The language matters

Medicare threatens to cut off funding for HCA's Mission hospital

Supreme Court strikes down use of affirmative action

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

As demand for Covid shots wanes, Moderna seeks its next success

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Anesthesiologist group: stop taking Ozempic before surgery

Health care court cases: Humana, Sutter, Novant

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

entertainment

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Cigna wins case to block Amy Bricker's move to CVS

Key House Republican on health care plans exit from Congress

Vaccine advisory panel ACIP left half staffed by HHS

Private equity deals in Medicare Advantage declines

My daughter's legacy lives on through her writing, phage therapy

focus

entertainment

hotspot

Wikipedia